Refine
Year of publication
Has Fulltext
- yes (71)
Is part of the Bibliography
- no (71)
Keywords
- autophagy (8)
- glioblastoma (5)
- apoptosis (3)
- cell biology (3)
- phosphorylation (3)
- ubiquitin (3)
- ubiquitination (3)
- Autophagy (2)
- BAG3 (2)
- Biochemistry (2)
- Cell biology (2)
- USP28 (2)
- Ubiquitylation (2)
- aging (2)
- c-MYC (2)
- cell death (2)
- cell migration (2)
- epithelial to mesenchymal transition (2)
- human (2)
- inflammation (2)
- lung cancer (2)
- mouse (2)
- oligomerisation (2)
- primary cilium (2)
- receptor (2)
- triple-negative breast cancer (2)
- 3Cs technology (1)
- AML – acute myeloid leukemia (1)
- AMPK (1)
- ATG4 (1)
- ATG8 (1)
- BRAF (1)
- BRD4 (1)
- BRD4-NUT (1)
- Bag6 (1)
- Biological Activity (1)
- Buparlisib (1)
- C. elegans (1)
- Calnexin (1)
- Cancer (1)
- Conventional and unconventional ubiquitination (1)
- Crispr/Cas (1)
- DNA damage (1)
- DNA replication (1)
- DNA-protein crosslinks (1)
- DUBs (1)
- Doxorubicin (1)
- Drug Discovery (1)
- Dvc1 (1)
- E. coli (1)
- E3-Ligases (1)
- EGFR (1)
- Endoplasmic reticulum (1)
- FAM134B (1)
- Feasibility (1)
- Fluorescent Probes (1)
- G9a/EHMT2/KMT1C (1)
- HRAS 28 Gefitinib (1)
- Hedgehog (1)
- Immunology (1)
- KCGS (1)
- LAMTOR1 (1)
- LC3/GABARAP (1)
- LC3B (1)
- LIR (1)
- LIR interaction, (1)
- LPS (1)
- LUBAC (1)
- Legionella pneumophila (1)
- Manatee invariant (1)
- Mathematical model (1)
- Microbiology (1)
- Mislocalised proteins (1)
- Mitophagy (1)
- NF-κB (1)
- NF-κB pathway (1)
- Notch (1)
- PIK3CA (1)
- Pathogens (1)
- Petri net (1)
- Phosphorylation (1)
- Profiling Transthiolation Activity (1)
- Proteasomes (1)
- Protein Structure (1)
- Protein degradation (1)
- Protein-Protein Interactions (1)
- ROS (1)
- RUFY (1)
- Rab7 (1)
- Ragulator complex (1)
- Research article (1)
- Reticulon (1)
- Rtn3 (1)
- Ruijs-Aalfs syndrome (1)
- S. cerevisiae (1)
- SARS-CoV-2 (1)
- SIRT1 (1)
- SPARTAN (1)
- SPRTN (1)
- Selective autophagy (1)
- Sharpin (1)
- Signal Transduction (1)
- Signaling pathway (1)
- Skp (1)
- TAX1BP1 (1)
- TBK1 (1)
- TNFR1 (1)
- TPR (1)
- Tools and ressources (1)
- Topoisomerase (1)
- Transition invariant (1)
- UBA5 (1)
- UFIM (1)
- UFM1 (1)
- USP32 (1)
- Ubiquitin Ligase (1)
- Ubiquitin signaling (1)
- Ubiquitin-binding module (1)
- Ubiquitination (1)
- Vemurafenib (1)
- WRNIP1 (1)
- X-ray Crystallography (1)
- alveolar macrophages (1)
- antiviral signaling (1)
- astrocytoma (1)
- bacteria (1)
- biochemistry (1)
- buparlisib (1)
- c-JUN (1)
- c1orf124 (1)
- calcitriol (1)
- cancer (1)
- cancer stem cells (1)
- chemogenomic set (1)
- collagen (1)
- cytarabin (1)
- deubiquitinase (DUB) (1)
- differentiation (1)
- drug discovery (1)
- druggable genome (1)
- endoplasmic reticulum (1)
- famotidine (1)
- fasting (1)
- gRNA library (1)
- gefitinib (1)
- genetics and genomics (1)
- genome-wide (1)
- glioblastoma stem-like cells (1)
- green fluorescent protein (1)
- hMOF/KAT8 (1)
- histamine (1)
- immunology (1)
- inhibitors (1)
- innate immunity (1)
- isothermal titration calorimetry (ITC) (1)
- kinase inhibitor (1)
- life span (1)
- lysosomes (1)
- mTORC1 (1)
- metabolic syndromes (1)
- metabolism (1)
- metalloprotease (1)
- mitochondrial metabolism (1)
- mitochondrial morphology (1)
- mitophagy (1)
- neurodegeneration (1)
- novel technologies (1)
- nuclear hormone receptor (1)
- nuclear magnetic resonance (NMR) (1)
- phage display (1)
- phenotypic screening (1)
- pol g (1)
- progeria (1)
- protein kinase (1)
- protein motif (1)
- selective autophagy (1)
- selective autophagy receptor (1)
- short linear motifs (SLiMs) (1)
- signal transduction (1)
- skin inflammation (1)
- small molecules (1)
- stress response (1)
- teratoma (1)
- toll-like receptor (1)
- transcriptional regulation of autophagy (1)
- ubiquitin-binding zinc finger (1)
- understudied kinase (1)
- v-ATPase (1)
- vemurafenib (1)
- viruses (1)
- vitamin D3 (1)
- x-ray crystallography (1)
Institute
- Medizin (60)
- Buchmann Institut für Molekulare Lebenswissenschaften (BMLS) (19)
- Exzellenzcluster Makromolekulare Komplexe (14)
- Biochemie und Chemie (11)
- Biochemie, Chemie und Pharmazie (5)
- Biowissenschaften (4)
- MPI für Biophysik (4)
- Physik (3)
- Informatik (2)
- Biodiversität und Klima Forschungszentrum (BiK-F) (1)
The turnover of endoplasmic reticulum (ER) ensures the correct biological activity of its distinct domains. In mammalian cells, the ER is degraded via a selective autophagy pathway (ER-phagy), mediated by two specific receptors: FAM134B, responsible for the turnover of ER sheets and SEC62 that regulates ER recovery following stress. Here, we identified reticulon 3 (RTN3) as a specific receptor for the degradation of ER tubules. Oligomerization of the long isoform of RTN3 is sufficient to trigger fragmentation of ER tubules. The long N-terminal region of RTN3 contains several newly identified LC3-interacting regions (LIR). Binding to LC3s/GABARAPs is essential for the fragmentation of ER tubules and their delivery to lysosomes. RTN3-mediated ER-phagy requires conventional autophagy components, but is independent of FAM134B. None of the other reticulon family members have the ability to induce fragmentation of ER tubules during starvation. Therefore, we assign a unique function to RTN3 during autophagy.
Ubiquitylation in immune disorders and cancer: from molecular mechanisms to therapeutic implications
(2012)
Conjugation of ubiquitin to proteins (ubiquitylation) has emerged to be one of the most crucial post-translational modifications controlling virtually all cellular processes. What was once regarded as a mere signal for protein degradation has turned out to be a major regulator of molecular signalling networks. Deregulation of ubiquitin signalling is closely associated with various human pathologies. Here, we summarize the current knowledge of ubiquitin signalling in immune deficiencies and cancer as well as the available therapeutic strategies targeting the ubiquitin system in combating these pathogenic conditions.
SHARPIN (SHANK-associated RH domain interacting protein) is part of a large multi-protein E3 ubiquitin ligase complex called LUBAC (linear ubiquitin chain assembly complex), which catalyzes the formation of linear ubiquitin chains and regulates immune and apoptopic signaling pathways. The C-terminal half of SHARPIN contains ubiquitin-like domain and Npl4-zinc finger domains that mediate the interaction with the LUBAC subunit HOIP and ubiquitin, respectively. In contrast, the N-terminal region does not show any homology with known protein interaction domains but has been suggested to be responsible for self-association of SHARPIN, presumably via a coiled-coil region. We have determined the crystal structure of the N-terminal portion of SHARPIN, which adopts the highly conserved pleckstrin homology superfold that is often used as a scaffold to create protein interaction modules. We show that in SHARPIN, this domain does not appear to be used as a ligand recognition domain because it lacks many of the surface properties that are present in other pleckstrin homology fold-based interaction modules. Instead, it acts as a dimerization module extending the functional applications of this superfold.
The degradation of cytosol-invading pathogens by autophagy, a process known as xenophagy, is an important mechanism of the innate immune system. Inside the host, Salmonella Typhimurium invades epithelial cells and resides within a specialized intracellular compartment, the Salmonella-containing vacuole. A fraction of these bacteria does not persist inside the vacuole and enters the host cytosol. Salmonella Typhimurium that invades the host cytosol becomes a target of the autophagy machinery for degradation. The xenophagy pathway has recently been discovered, and the exact molecular processes are not entirely characterized. Complete kinetic data for each molecular process is not available, so far. We developed a mathematical model of the xenophagy pathway to investigate this key defense mechanism. In this paper, we present a Petri net model of Salmonella xenophagy in epithelial cells. The model is based on functional information derived from literature data. It comprises the molecular mechanism of galectin-8-dependent and ubiquitin-dependent autophagy, including regulatory processes, like nutrient-dependent regulation of autophagy and TBK1-dependent activation of the autophagy receptor, OPTN. To model the activation of TBK1, we proposed a new mechanism of TBK1 activation, suggesting a spatial and temporal regulation of this process. Using standard Petri net analysis techniques, we found basic functional modules, which describe different pathways of the autophagic capture of Salmonella and reflect the basic dynamics of the system. To verify the model, we performed in silico knockout experiments. We introduced a new concept of knockout analysis to systematically compute and visualize the results, using an in silico knockout matrix. The results of the in silico knockout analyses were consistent with published experimental results and provide a basis for future investigations of the Salmonella xenophagy pathway.
Author Summary
Salmonellae are Gram-negative bacteria, which cause the majority of foodborne diseases worldwide. Serovars of Salmonella cause a broad range of diseases, ranging from diarrhea to typhoid fever in a variety of hosts. In the year 2010, Salmonella Typhi caused 7.6 million foodborne diseases and 52 000 deaths, and Salmonella enterica was responsible for 78.7 million diseases and 59 000 deaths. After invasion of Salmonella into host epithelial cells, a small fraction of Salmonella escapes from a specialized intracellular compartment and replicates inside the host cytosol. Xenophagy is a host defense mechanism to protect the host cell from cytosolic pathogens. Understanding how Salmonella is recognized and targeted for xenophagy is an important subject of current research. To the best of our knowledge, no mathematical model has been presented so far, describing the process of Salmonella Typhimurium xenophagy. Here, we present a manually curated and mathematically verified theoretical model of Salmonella Typhimurium xenophagy in epithelial cells, which is consistent with the current state of knowledge. Our model reproduces literature data and postulates new hypotheses for future investigations.
Protein post-translational modification with ubiquitin (Ub) is a versatile signal regulating almost all aspects of cell biology, and an increasing range of diseases is associated with impaired Ub modification. In this light, the Ub system offers an attractive, yet underexplored route to the development of novel targeted treatments. A promising strategy for small molecule intervention is posed by the final components of the enzymatic ubiquitination cascade, E3 ligases, as they determine the specificity of the protein ubiquitination pathway. Here, we present UbSRhodol, an autoimmolative Ub-based probe, which upon E3 processing liberates the pro-fluorescent dye, amenable to profile the E3 transthiolation activity for recombinant and in cell-extract E3 ligases. UbSRhodol enabled detection of changes in transthiolation efficacy evoked by enzyme key point mutations or conformational changes, and offers an excellent assay reagent amenable to a high-throughput screening setup allowing the identification of small molecules modulating E3 activity.
The Kinase Chemogenomic Set (KCGS): an open science resource for kinase vulnerability identification
(2021)
We describe the assembly and annotation of a chemogenomic set of protein kinase inhibitors as an open science resource for studying kinase biology. The set only includes inhibitors that show potent kinase inhibition and a narrow spectrum of activity when screened across a large panel of kinase biochemical assays. Currently, the set contains 187 inhibitors that cover 215 human kinases. The kinase chemogenomic set (KCGS), current Version 1.0, is the most highly annotated set of selective kinase inhibitors available to researchers for use in cell-based screens.
The Kinase Chemogenomic Set (KCGS): An open science resource for kinase vulnerability identification
(2019)
We describe the assembly and annotation of a chemogenomic set of protein kinase inhibitors as an open science resource for studying kinase biology. The set only includes inhibitors that show potent kinase inhibition and a narrow spectrum of activity when screened across a large panel of kinase biochemical assays. Currently, the set contains 187 inhibitors that cover 215 human kinases. The kinase chemogenomic set (KCGS) is the most highly annotated set of selective kinase inhibitors available to researchers for use in cell-based screens.
SUMO proteins are ubiquitin-related modifiers implicated in the regulation of gene transcription, cell cycle, DNA repair, and protein localization. The molecular mechanisms by which the sumoylation of target proteins regulates diverse cellular functions remain poorly understood. Here we report isolation and characterization of SUMO1- and SUMO2-binding motifs. Using yeast two-hybrid system, bioinformatics, and NMR spectroscopy we define a common SUMO-interacting motif (SIM) and map its binding surfaces on SUMO1 and SUMO2. This motif forms a beta-strand that could bind in parallel or antiparallel orientation to the beta2-strand of SUMO due to the environment of the hydrophobic core. A negative charge imposed by a stretch of neighboring acidic amino acids and/or phosphorylated serine residues determines its specificity in binding to distinct SUMO paralogues and can modulate the spatial orientation of SUMO-SIM interactions.
Defects in podocyte signaling are the basis of many inherited glomerular diseases leading to glomerulosclerosis. CD2-associated protein (CD2AP) is highly expressed in podocytes and is considered to play an important role in the maintenance of the glomerular slit diaphragm. Mice deficient for CD2AP (CD2AP(-/-)) appear normal at birth but develop a rapid onset nephrotic syndrome at 3 weeks of age. We demonstrate that impaired intracellular signaling with subsequent podocyte damage is the reason for this delayed podocyte injury in CD2AP(-/-) mice. We document that CD2AP deficiency in podocytes leads to diminished signal initiation and termination of signaling pathways mediated by receptor tyrosine kinases (RTKs). In addition, we demonstrate that CIN85, a paralog of CD2AP, is involved in termination of RTK signaling in podocytes. CIN85 protein expression is increased in CD2AP(-/-) podocytes in vitro. Stimulation of CD2AP(-/-) podocytes with various growth factors, including insulin-like growth factor 1, vascular endothelial growth factor, and fibroblast growth factor, resulted in a significantly decreased phosphatidylinositol 3-kinase/AKT and ERK signaling response. Moreover, increased CIN85 protein is detectable in podocytes in diseased CD2AP(-/-) mice, leading to decreased base-line activation of ERK and decreased phosphorylation after growth factor stimulation in vivo. Because repression of CIN85 protein leads to a restored RTK signaling response, our results support an important role of CD2AP/CIN85 protein balance in the normal signaling response of podocytes.
Reversible phosphorylation plays important roles in G protein-coupled receptor signaling, desensitization, and endocytosis, yet the precise location and role of in vivo phosphorylation sites is unknown for most receptors. Using metabolic 32P labeling and phosphopeptide sequencing we provide a complete phosphorylation map of the human bradykinin B2 receptor in its native cellular environment. We identified three serine residues, Ser(339), Ser(346), and Ser(348), at the C-terminal tail as principal phosphorylation sites. Constitutive phosphorylation occurs at Ser(348), while ligand-induced phosphorylation is found at Ser(339) and Ser(346)/Ser(348) that could be executed by several G protein-coupled receptor kinases. In addition, we found a protein kinase C-dependent phosphorylation of Ser(346) that was mutually exclusive with the basal phosphorylation at Ser(348) and therefore may be implicated in differential regulation of B2 receptor activation. Functional analysis of receptor mutants revealed that a low phosphorylation stoichiometry is sufficient to initiate receptor sequestration while a clustered phosphorylation around Ser(346) is necessary for desensitization of the B2 receptor-induced phospholipase C activation. This was further supported by the specifically reduced Ser(346)/Ser(348) phosphorylation observed upon stimulation with a nondesensitizing B2 receptor agonist. The differential usage of clustered phosphoacceptor sites points to distinct roles of multiple kinases in controlling G protein-coupled receptor function.